225 related articles for article (PubMed ID: 12535819)
1. Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis.
Chevalier P; Durand-Dubief A; Burri H; Cucherat M; Kirkorian G; Touboul P
J Am Coll Cardiol; 2003 Jan; 41(2):255-62. PubMed ID: 12535819
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs.
Bonora A; Turcato G; Franchi E; Taioli G; Dilda A; Zerman G; Maccagnani A; Pistorelli C; Olivieri O
Intern Emerg Med; 2017 Sep; 12(6):853-859. PubMed ID: 27384766
[TBL] [Abstract][Full Text] [Related]
3. Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials.
Hilleman DE; Spinler SA
Pharmacotherapy; 2002 Jan; 22(1):66-74. PubMed ID: 11794432
[TBL] [Abstract][Full Text] [Related]
4. Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation.
Koskinas KC; Fragakis N; Katritsis D; Skeberis V; Vassilikos V
Europace; 2014 Jul; 16(7):973-9. PubMed ID: 24473502
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic effects of ranolazine used both alone for prevention of atrial fibrillation and as an add-on to intravenous amiodarone for its pharmacological cardioversion: a meta-analysis.
De Vecchis R; Ariano C; Giasi A; Cioppa C
Minerva Cardioangiol; 2018 Jun; 66(3):349-359. PubMed ID: 28497941
[TBL] [Abstract][Full Text] [Related]
6. Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation.
Cybulski J; Kułakowski P; Budaj A; Danielewicz H; Maciejewicz J; Kawka-Urbanek T; Ceremuzyński L
Clin Cardiol; 2003 Jul; 26(7):329-35. PubMed ID: 12862299
[TBL] [Abstract][Full Text] [Related]
7. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation.
Khan IA; Mehta NJ; Gowda RM
Int J Cardiol; 2003 Jun; 89(2-3):239-48. PubMed ID: 12767548
[TBL] [Abstract][Full Text] [Related]
9. Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials.
Ibrahim OA; Belley-Côté EP; Um KJ; Baranchuk A; Benz AP; Dalmia S; Wang CN; Alhazzani W; Conen D; Devereaux PJ; Whitlock RP; Healey JS; McIntyre WF
Europace; 2021 Aug; 23(8):1200-1210. PubMed ID: 33723602
[TBL] [Abstract][Full Text] [Related]
10. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment with antiarrhythmic drugs for elective electrical cardioversion of atrial fibrillation: a systematic review and network meta-analysis.
Um KJ; McIntyre WF; Mendoza PA; Ibrahim O; Nguyen ST; Lin SH; Duceppe E; Rochwerg B; Healey JS; Koziarz A; Lengyel AP; Bhatnagar A; Amit G; Chu VA; Whitlock RP; Belley-Côté EP
Europace; 2022 Oct; 24(10):1548-1559. PubMed ID: 35654763
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis.
deSouza IS; Tadrous M; Sexton T; Benabbas R; Carmelli G; Sinert R
Europace; 2020 Jun; 22(6):854-869. PubMed ID: 32176779
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Lafuente-Lafuente C; Mouly S; Longas-Tejero MA; Bergmann JF
Cochrane Database Syst Rev; 2007 Oct; (4):CD005049. PubMed ID: 17943835
[TBL] [Abstract][Full Text] [Related]
14. Intravenous amiodarone for conversion of atrial fibrillation: misled by meta-analysis?
Slavik RS; Zed PJ
Pharmacotherapy; 2004 Jun; 24(6):792-8. PubMed ID: 15222670
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs.
Balla I; Petrela E; Kondili A
Anadolu Kardiyol Derg; 2011 Nov; 11(7):600-6. PubMed ID: 21911317
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological cardioversion of atrial fibrillation: current management and treatment options.
Boriani G; Diemberger I; Biffi M; Martignani C; Branzi A
Drugs; 2004; 64(24):2741-62. PubMed ID: 15563247
[TBL] [Abstract][Full Text] [Related]
17. Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
Gulizia M; Mangiameli S; Chiarandà G; Spadola V; Di Giovanni N; Colletti A; Bulla V; Circo A; Pensabene O; Vasquez L; Vaccaro I; Grammatico A;
Europace; 2006 Apr; 8(4):302-5. PubMed ID: 16627459
[TBL] [Abstract][Full Text] [Related]
18. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
Cotter G; Blatt A; Kaluski E; Metzkor-Cotter E; Koren M; Litinski I; Simantov R; Moshkovitz Y; Zaidenstein R; Peleg E; Vered Z; Golik A
Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Intravenous and Oral Sotalol in Pharmacologic Conversion of Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Milan DJ; Saul JP; Somberg JC; Molnar J
Cardiology; 2017; 136(1):52-60. PubMed ID: 27554842
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review and Meta-analysis Appraising Efficacy and Safety of Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation.
Ma W; Guo X; Wang Q; Sun G; Wang J
J Cardiovasc Pharmacol; 2020 Jul; 76(1):32-41. PubMed ID: 32251022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
